Viagra and Cancer Treatment: A New Hope

Sildenafil, the active ingredient in the erectile dysfunction drug Viagra, may help prevent cancer cells from spreading by disrupting how they process cholesterol, according to a study published by researchers at the Weizmann Institute of Science in Israel. The findings, released in the journal Cancer Research, point to a newly discovered biological pathway that researchers suggest could eventually lead to novel treatments for metastatic cancers.

How Sildenafil Intersects With Cholesterol and Cancer Cells

Cancer cells rely on distinct chemical chain reactions compared to normal cells to fuel their growth and spread throughout the body. According to senior study author Ayelet Erez, a cancer researcher at the Weizmann Institute of Science, the team uncovered a biological pathway linking a well-known signaling molecule to cellular cholesterol regulation.

Sildenafil primarily works by inhibiting the enzyme phosphodiesterase type 5 (PDE5), which blocks the breakdown of a molecule called cGMP. Higher levels of cGMP keep certain blood vessels dilated, which treats erectile dysfunction. However, the researchers discovered that cGMP can also bind to a protein responsible for transporting cholesterol within cells. By increasing cGMP levels, sildenafil slows down cholesterol transport inside cancer cells, reducing their ability to metastasize.

Patient Data and Real-World Survival Trends

To test these laboratory findings outside of petri dishes, the research team examined the medical records of five million patients within Clalit Health Services, Israel’s largest public healthcare provider. In their analysis, cancer patients who were also taking sildenafil appeared to survive longer than similar patients who did not take the drug.

Furthermore, when researchers combined sildenafil with statins—a class of cholesterol-lowering medications—the combination further limited cancer metastasis. Cancer patients in the medical records analysis who took both drugs together were even less likely to die from cancer.

What Researchers Caution About Next Steps

Despite the promising laboratory results and patient data trends, the researchers emphasize that this study alone does not prove sildenafil is a definitive cancer treatment. Many pharmaceutical compounds show success against cancer cells in a laboratory setting but ultimately yield no actual survival benefit in human clinical care.

Additional studies will be required to verify these findings and determine whether the observed effects are clinically meaningful. However, the discovery of this cholesterol-transport pathway provides a mechanistic basis for the beneficial effects observed and opens the door for other drugs to exploit the same vulnerability.

Frequently Asked Questions

Does taking Viagra cure cancer?

How does sildenafil affect cholesterol in cells?

Sildenafil inhibits the PDE5 enzyme, which raises cGMP levels. This molecule binds to a protein that transports cholesterol inside cells, slowing down the transport process that cancer cells rely on to spread.

Did researchers test sildenafil with other drugs?

Yes. When researchers combined sildenafil with statins—cholesterol-lowering medications—they observed a further reduction in cancer metastasis and improved survival outcomes in patient records.